157 related articles for article (PubMed ID: 11419580)
1. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.
Thiede H; Romero M; Bordelon K; Hagan H; Murrill CS
J Urban Health; 2001 Jun; 78(2):264-78. PubMed ID: 11419580
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
5. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
[TBL] [Abstract][Full Text] [Related]
6. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.
Kitayaporn D; Vanichseni S; Mastro TD; Raktham S; Vaniyapongs T; Des Jarlais DC; Wasi C; Young NL; Sujarita S; Heyward WL; Esparza J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):289-95. PubMed ID: 9803972
[TBL] [Abstract][Full Text] [Related]
7. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.
Thiede H; Hagan H; Murrill CS
J Urban Health; 2000 Sep; 77(3):331-45. PubMed ID: 10976608
[TBL] [Abstract][Full Text] [Related]
8. At risk for HIV infection: incarcerated women in a county jail in Philadelphia.
Bond L; Semaan S
Women Health; 1996; 24(4):27-45. PubMed ID: 9104763
[TBL] [Abstract][Full Text] [Related]
9. Recent incarceration independently associated with syringe sharing by injection drug users.
Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T
Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116
[TBL] [Abstract][Full Text] [Related]
10. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
11. HIV sexual risk behaviors among injection drug users in Shanghai.
Zhao M; Du J; Lu GH; Wang QY; Xu H; Zhu M; McCoy CB
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
[TBL] [Abstract][Full Text] [Related]
12. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment.
Stark K; Müller R; Wirth D; Bienzle U; Pauli G; Guggenmoos-Holzmann I
Addiction; 1995 Oct; 90(10):1367-75. PubMed ID: 8616465
[TBL] [Abstract][Full Text] [Related]
13. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
Li L; Assanangkornchai S; Duo L; McNeil E; Li J
PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
[TBL] [Abstract][Full Text] [Related]
14. Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study.
Brodish P; Singh K; Rinyuri A; Njeru C; Kingola N; Mureithi P; Sambisa W; Weir S
Drug Alcohol Depend; 2011 Dec; 119(1-2):138-41. PubMed ID: 21700402
[TBL] [Abstract][Full Text] [Related]
15. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
[TBL] [Abstract][Full Text] [Related]
16. HIV risk behaviors of male injecting drug users and associated non-condom use with regular female sexual partners in north-east India.
Mishra RK; Ganju D; Ramesh S; Lalmuanpuii M; Biangtung L; Humtsoe C; Saggurti N
Harm Reduct J; 2014 Feb; 11():5. PubMed ID: 24520914
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India.
Singh S; Prasad R; Mohanty A
Int J STD AIDS; 1999 Jul; 10(7):475-8. PubMed ID: 10454185
[TBL] [Abstract][Full Text] [Related]
18. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
Alipour A; Haghdoost AA; Sajadi L; Zolala F
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
[TBL] [Abstract][Full Text] [Related]
19. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
[TBL] [Abstract][Full Text] [Related]
20. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]